73.7 F
New York
HomeMedicine

Medicine

Dr. Susan Love’s Legacy Continues with the Tower Cancer Research Foundation

LOS ANGELES, Jan. 8, 2024 /PRNewswire/ -- In the ongoing work to end breast cancer, the work of Dr. Susan Love will transcend her lifetime to be integrated into research, clinical work and breast cancer awareness education around the globe. Tower Cancer Research Foundation Dr....

IEHP earns NCQA Health Equity Accreditation

RANCHO CUCAMONGA, Calif., Jan. 9, 2024 /PRNewswire/ -- Inland Empire Health Plan (IEHP) received Health Equity Accreditation by the National Committee for Quality Assurance (NCQA), becoming one of two public health plans in the state to earn the designation."This honor represents another milestone in IEHP's...

Cityblock Highlights Impact on Members, Increase in Engagement & Reductions in Cost in Second Annual Equity in Action Report

BROOKLYN, N.Y. , Jan. 8, 2024 /PRNewswire/ -- Cityblock announced today the publication of its second annual Equity in Action Report. This report highlights the progress and impact the company has made in providing high-quality healthcare for the most underserved populations. The report also details steps...

LEADING PROSTHETIC MANUFACTURER, WILLOWWOOD, HIRES NEW MANAGEMENT TEAM MEMBER INTO STRATEGIC M&A POSITION

MOUNT STERLING, Ohio, Jan. 8, 2024 /PRNewswire/ -- As part of its long-term commitment to sustained growth through innovation, WillowWood announced the hiring of Richard Hayes into the newly created position of Executive Vice President, Strategy and M&A. With more than thirty years' experience in...

PharmacyChecker Statement on Federal Court’s Denial of LegitScript’s Motion to Block Antitrust Lawsuit

WHITE PLAINS, N.Y., Jan. 8, 2024 /PRNewswire/ -- In response to U.S. District Judge Michael H. Simon's January 3, 2023, ruling to deny a motion by LegitScript, LLC for summary judgment and to stay discovery in an antitrust lawsuit filed against it by PharmacyChecker.com, LLC,...

Global Xerostomia Therapeutics Market Research Report 2023-2030: Analysis of Salivary Stimulants, Salivary Substitutes, and Dentifrices

DUBLIN, Jan. 8, 2024 /PRNewswire/ -- The "Xerostomia Therapeutics Market Size, Share & Trends Analysis Report By Type (OTC, Prescription), By Product (Salivary Stimulants, Salivary Substitutes, Dentifrices), By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering. The global xerostomia therapeutics market...